Formula Grant HT94252510157
Award Date
4/1/25
Completion Date
3/31/26
Dollars Obligated
$185K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Formula Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of...
The U.S. Department of Defense, through its Military Medical Research and Development program (CFDA 12.420), awarded a $750,000 Project Grant to The Leland Stanford Junior University. The grant, with a performance period from September 1, 2024 to August 31, 2027, supports the implementation of a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. As a leading research institution, Stanford University will...
This $926,400 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The Leland Stanford Junior University. The grant will fund a 3-year research project to conduct an "Integrated Immunophenotypic Transcriptomic and Epigenomic Characterization of Uterine Mesenchymal Neoplasms with Expert Pathologist Panel Review". The objectives are to advance scientific understanding and develop new treatments for these...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
The Defense Health Agency awarded The Leland Stanford Junior University a $1,500,084 project grant under the Military Medical Research and Development program to support research on detecting cartilage surface degeneration using photon counting CT and solute transport modeling. This grant will fund research from July 1, 2023 through June 30, 2027 aimed at transforming military and public health care through innovative medical solutions applicable to battlefield conditions. The Military...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,225,171 to The Leland Stanford Junior University to conduct research on the early detection of kidney cancer using tumor-educated platelets. The performance period for this award runs from August 1, 2024 to July 31, 2028. As a leading private research institution, Stanford University will leverage its expertise in medicine, engineering, and...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $750,000 Project Grant to The Leland Stanford Junior University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The award period runs from September 1, 2024 to August 31, 2027. This grant funding will enable Stanford University, a renowned private research institution, to...
The Leland Stanford Junior University has been awarded a $1,291,660.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on May 15, 2024, will fund foundational studies to understand phenotypic, region-specific, and cell-specific dysregulation in the myotonic dystrophy central nervous system, with a period of performance through May 14, 2028. This federal grant award supports the university's expertise in...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,795,499 project grant to The Leland Stanford Junior University, doing business as Stanford University, to conduct an evaluation of clinical responders with advanced triple-negative breast cancer from the KEYNOTE-890 study. The purpose of this 4-year project is to validate a published CXCR3 gene signature that may help identify patients likely to respond to certain cancer...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $397,510.00 to The Leland Stanford Junior University (Stanford University) to conduct research on "REVEALING AND TARGETING LIPIDOMIC VULNERABILITIES TO TREAT METASTATIC MELANOMA". The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research, with a focus on cancer therapies. The award...